health
Harmine Combo Aided Anti-CD3 Diabetes Remission in Mice
A bioRxiv preprint reports that harmine plus exendin-4, given after low-dose anti-CD3 therapy, promoted remission in diabetic mice. Human cell experiments also showed effects on beta-cell function and immune responses.